BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37654790)

  • 1. Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome.
    Nashiry MA; Sumi SS; Alyami SA; Moni MA
    Front Mol Neurosci; 2023; 16():1232805. PubMed ID: 37654790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric Manifestation in Patients with Parkinson's Disease.
    Han JW; Ahn YD; Kim WS; Shin CM; Jeong SJ; Song YS; Bae YJ; Kim JM
    J Korean Med Sci; 2018 Nov; 33(47):e300. PubMed ID: 30450025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation.
    Bacciardi S; Elefante C; Brancati GE; Mazzucchi S; Del Prete E; Frosini D; Maremmani I; Lattanzi L; Ceravolo R; Bonuccelli U; Perugi G
    CNS Spectr; 2022 Jun; 27(3):355-361. PubMed ID: 33280618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson's Disease and Bipolar Disorder: A Pilot Study.
    Hossain MB; Islam MK; Adhikary A; Rahaman A; Islam MZ
    Bioinform Biol Insights; 2022; 16():11779322221079232. PubMed ID: 35221677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Correlates of Psychiatric Comorbidity and Multimorbidity in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Patel V; Ts J; Kamble N; Yadav R; K T; Pal PK; Reddy Yc J
    J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):155-163. PubMed ID: 35579346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disorders.
    Chen Y; Dai J; Tang L; Mikhailova T; Liang Q; Li M; Zhou J; Kopp RF; Weickert C; Chen C; Liu C
    Mol Psychiatry; 2023 Feb; 28(2):710-721. PubMed ID: 36424395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel diagnostic biomarkers related to immune infiltration in Parkinson's disease by bioinformatics analysis.
    Zhang P; Zhao L; Li H; Shen J; Li H; Xing Y
    Front Neurosci; 2023; 17():1083928. PubMed ID: 36777638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder.
    Nakamura S
    Front Biosci (Schol Ed); 2022 Jan; 14(1):4. PubMed ID: 35320915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue.
    Moni MA; Rana HK; Islam MB; Ahmed MB; Xu H; Hasan MAM; Lei Y; Quinn JMW
    Comput Biol Med; 2019 Oct; 113():103385. PubMed ID: 31437626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural and behavioral substrates of subtypes of Parkinson's disease.
    Moustafa AA; Poletti M
    Front Syst Neurosci; 2013 Dec; 7():117. PubMed ID: 24399940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease.
    Steinlechner S; Hagenah J; Rumpf HJ; Meyer C; John U; Bäumer T; Brüggemann N; Kasten M; Münchau A; Klein C; Lencer R
    J Neurol; 2017 Jun; 264(6):1076-1084. PubMed ID: 28401296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind].
    Rutten S; Vriend C; Berendse HW; Van der Werf YD; van den Heuvel OA
    Tijdschr Psychiatr; 2020; 62(1):62-72. PubMed ID: 31994713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.
    Dos Santos AB; Bezerra MA; Rocha ME; Barreto GE; Kohlmeier KA
    J Neural Transm (Vienna); 2019 Oct; 126(10):1291-1301. PubMed ID: 31297591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity in a population of Parkinson's disease patients.
    Nuti A; Ceravolo R; Piccinni A; Dell'Agnello G; Bellini G; Gambaccini G; Rossi C; Logi C; Dell'Osso L; Bonuccelli U
    Eur J Neurol; 2004 May; 11(5):315-20. PubMed ID: 15142224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Psychiatric Disorders in Patients with Parkinson's Diseases.
    Tripathi A; Gupta PK; Bansal T
    Indian J Psychiatry; 2022 Mar; 64(Suppl 2):S330-S343. PubMed ID: 35602377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.